THE ROLE OF THE MURINE HOMEOBOX GENE CUX-1 IN KIDNEY DEVELOPMENT AND POLYCYSTIC KIDNEY DISEASE
View/ Open
Issue Date
2008-02-25Author
Alcalay, Neal
Publisher
University of Kansas
Format
187 pages
Type
Dissertation
Degree Level
PH.D.
Discipline
Anatomy & Cell Biology
Rights
This item is protected by copyright and unless otherwise specified the copyright of this thesis/dissertation is held by the author.
Metadata
Show full item recordAbstract
The murine homeobox gene cux-1 is evolutionarily conserved in drosophila, mice and humans. Cux-1 contains four DNA binding domains (3 cut repeat domains and a homeodomain) and functions as a transcription factor that represses the expression of the cyclin kinase inhibitor p27 during S-phase of the cell-cycle. Cux-1 is highly expressed in proliferating cells within the nephrogenic zone of developing kidneys. The role of Cux-1 during kidney development and Polycystic Kidney Disease (PKD) is unclear. Cux-1 is a transcription factor that binds to DNA when it is dephosphorylated. Calcineurin A (CnA) is a phosphatase that might be involved in regulating Cux-1 as both are expressed during early kidney development. Previous studies demonstrated that CnA knockout (-/-) mice display renal hypoplasia associated with ectopic expression of p27 in the nephrogenic zone. The opposite phenotype was observed when Cux-1 is overexpressed. Therefore metanephric kidney cultures, overexpressing Cux-1 were grown in the presence of cyclosporine A to inhibit Calcineurin. Overexpression of Cux-1 rescued growth inhibition due to Calcineurin inhibition. Calcineurin inhibition resulted in increased phospho-Cux-1 levels suggesting that Calcineurin may regulate Cux-1 and thus revealing a new pathway in kidney development. The cpk mouse model is the most widely characterized model for PKD. A hallmark of PKD is increased cell proliferation. The mechanism of cell proliferation in PKD is unclear although deregulation of cyclin kinase inhibitors appears to be involved. Cux-1 is highly expressed in cpk kidneys, however it is unclear if Cux-1 is required for PKD. The results here demonstrate that a mutation of Cux-1 (cux-1∆CR1) which lacks a Cathepsin-L proteolytic cleavage site, results in severe PKD when crossed onto cpk mice. Upregulation of Cux-1∆CR1 was observed and correlated with attenuated levels of p27 within cpk kidneys which suggests a potential mechanism for the acceleration of PKD. Alteration of the PKD phenotype by Cux-1 suggests that Cux-1 may act as a candidate modifier gene of PKD. The collection of studies presented within this body of work has helped to elucidate the importance of Cux-1 regulation by post-translational modification which requires further investigation as a critical factor in kidney development and PKD.
Collections
- Dissertations [4700]
- KU Med Center Dissertations and Theses [464]
Items in KU ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
We want to hear from you! Please share your stories about how Open Access to this item benefits YOU.